Medexus Pharmaceuticals Inc. (TSX:MDP)
Canada · Delayed Price · Currency is CAD 5.06
-0.04 (-0.78%)
Sep 4, 2026, 4:00 PM EST
Medexus Pharmaceuticals Market Cap
Medexus Pharmaceuticals has a market cap or net worth of CAD 160.27 million as of September 4, 2026. Its market cap has increased by 61.58% in one year.
Market Cap
160.27M
Enterprise Value
189.97M
Revenue
146.70M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.06
ChartMarket Cap Chart
Since December 27, 2013, Medexus Pharmaceuticals's market cap has increased from 32.21M to 160.27M, an increase of 397.64%. That is a compound annual growth rate of 13.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 160.27M | 69.72% |
| Dec 31, 2025 | 94.44M | 10.49% |
| Dec 31, 2024 | 85.47M | 41.48% |
| Dec 29, 2023 | 60.41M | 45.19% |
| Dec 30, 2022 | 41.61M | -17.74% |
| Dec 31, 2021 | 50.58M | -48.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cardiol Therapeutics | 353.97M |
| Auxly Cannabis Group | 324.16M |
| TerrAscend | 272.07M |
| Organigram Global | 230.87M |
| Cannara Biotech | 197.56M |
| BioSyent | 179.47M |
| Grown Rogue International | 154.96M |
| HLS Therapeutics | 116.01M |